Funding sources, Fundraising, Bioinformatics, Biotech, Cancer therapeutics, Drug Discovery, Genomics, Health tech, Oncology, Personalised medicine, Business strategy, Startups, Capital raising, Drug discovery, Entrepreneurship, CRISPR, Genome Editing, CAR-T
Successful deep-tech entrepreneur working at the intersection of informatics technology and genomics to develop the next generation of tools and products in advanced curative treatments and personalised medicine. Founded bioinformatics startup in 2012, grew to become leading genome editing software solutions provider, sold in 2018 to cell therapy company. Secured $4M in venture financing, $3M in revenue, $1M in non-dilutive funding, commercial contracts with 7 of top 10 biopharmaceutical companies, enabled 2 successful IND approvals.
Chief Executive Officer, Desktop Genetics Ltd. (2018-) [London UK]
VP, Gene Editing, Celixir (2018-) [London UK]
Founder and Chief Operating Officer, Desktop Genetics Ltd. (2012-2018) [London UK]
Entrepreneurial Fellow, Flagship Pioneering (2012) [Boston MA]
MPhil (Hons.), University of Cambridge (2012)
MEng (Hons.), Imperial College London (2011)